CAMBRIDGE, Mass., Jan. 19, 2021 Mersana Therapeutics, Inc. (Nasdaq: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing
The U.S. property/casualty (P/C) industry in the past five years has paid out $16.1 billion for asbestos and environmental (A&E) claims while incurring
Wavemaker US Appoints New Chief Strategy Officer
Wavemaker US Appoints New Chief Strategy Officer
NEW YORK, Jan. 21, 2021 Wavemaker has appointed Dennis Potgraven to the role of Chief Strategy Officer U.S., effective immediately. Dennis will be responsible for leading Wavemaker’s Strategy and Planning practice, activating Wavemaker’s Provocative Planning approach to create new growth opportunities across a diverse client portfolio.
Dennis joins from Havas Group, where he led the strategy teams for the creative, digital and media businesses as Chief Strategy Officer for the greater Chinese market. An international marketing professional, Dennis brings extensive agency experience in establishing brands, delivering integrated marketing communication and creating customer value.
CALGARY, Alberta, Jan. 19, 2021 Established in 2004, the MarCom Awards honor excellence in marketing and communications while recognizing the creativity